Elissa J. Schwartz

Dr. Elissa J. Schwartz

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Mathematical Biosciences
Verified
Journal Article
Closed access
ESElissa J. Schwartz
Elissa J. Schwartz
BCBoseung Choi
Boseung Choi
GRGrzegorz Rempala
Grzegorz Rempala

17 July 2021 in Viruses
Verified
Journal Article
Open access
PDF file
KBKarin Biggs
Karin Biggs
CBClayton L. Bailes
Clayton L. Bailes
LSLuAnn Scott
LuAnn Scott
HWHolly A. Wichman
Holly A. Wichman
ESElissa J. Schwartz
Elissa J. Schwartz
In microbial communities, viruses compete with each other for host cells to infect. As a consequence of competition for hosts, viruses evolve inhibitory mechanisms to suppress their competitors. One such mechanism is superinfection exclusion, in which a preexisting viral infection prevents a secondary infection. The bacteriophage ΦX174 exhibits a potential superinfection inhibition mechanism (in which secondary infections are either blocked or resisted) known as the reduction effect. In this auto-inhibitory phenomenon, a plasmid containing a fragment of the ΦX174 genome confers resistance to infection among cells that were once permissive to ΦX174. Taking advantage of this plasmid system, we examine the inhibitory properties of the ΦX174 reduction effect on a range of wild ΦX174-like phages. We then assess how closely the reduction effect in the plasmid system mimics natural superinfection inhibition by carrying out phage–phage competitions in continuous culture, and we evaluate whether the overall competitive advantage can be predicted by phage fitness or by a combination of fitness and reduction effect inhibition. Our results show that viral fitness often correctly predicts the winner. However, a phage’s reduction sequence also provides an advantage to the phage in some cases, modulating phage–phage competition and allowing for persistence where competitive exclusion was expected. These findings provide strong evidence for more complex dynamics than were previously thought, in which the reduction effect may inhibit fast-growing viruses, thereby helping to facilitate coexistence.

1 January 2018 in Virology
Verified
Journal Article
Closed access
ESElissa J. Schwartz
Elissa J. Schwartz
NVNaveen K. Vaidya
Naveen K. Vaidya
KDKarin S. Dorman
Karin S. Dorman
SCSusan Carpenter
Susan Carpenter
RMRobert H. Mealey
Robert H. Mealey

1 July 2015 in Journal of Virology
Verified
Journal Article
Open access
PDF file
ESElissa J. Schwartz
Elissa J. Schwartz
SNSeema Nanda
Seema Nanda
RMRobert H. Mealey
Robert H. Mealey
Lentivirus escape from neutralizing antibodies (NAbs) is not well understood. In this work, we quantified antibody escape of a lentivirus, using antibody escape data from horses infected with equine infectious anemia virus. We calculated antibody blocking rates of wild-type virus, fitness costs of mutant virus, and growth rates of both viruses. These quantitative kinetic estimates of antibody escape are important for understanding lentiviral control by antibody neutralization and in developing NAb-eliciting vaccine strategies.

24 October 2016 in Current Clinical Microbiology Reports
Verified
Journal Article
Closed access
PDF file
ESElissa J. Schwartz
Elissa J. Schwartz
KBKarin R. H. Biggs
Karin R. H. Biggs
CBClayton Bailes
Clayton Bailes
KFKari A. Ferolito
Kari A. Ferolito
NVNaveen K. Vaidya
Naveen K. Vaidya

27 May 2014 in Vaccines
Verified
Journal Article
Open access
PDF file
ESElissa J. Schwartz
Elissa J. Schwartz
SSStacey Smith?
Stacey Smith?
The ability to predict the conditions under which antibodies protect against viral infection would transform our approach to vaccine development. A more complete understanding is needed of antibody protection against lentivirus infection, as well as the role of mutation in resistance to an antibody vaccine. Recently, an example of antibody-mediated vaccine protection has been shown via passive transfer of neutralizing antibodies before equine infectious anemia virus (EIAV) infection of horses with severe combined immunodeficiency (SCID). Viral dynamic modeling of antibody protection from EIAV infection in SCID horses may lead to insights into the mechanisms of control of infection by antibody vaccination. In this work, such a model is constructed in conjunction with data from EIAV infection of SCID horses to gain insights into multiple strain competition in the presence of antibody control. Conditions are determined under which wild-type infection is eradicated with the antibody vaccine. In addition, a three-strain competition model is considered in which a second mutant strain may coexist with the first mutant strain. The conditions that permit viral escape by the mutant strains are determined, as are the effects of variation in the model parameters. This work extends the current understanding of competition and antibody control in lentiviral infection, which may provide insights into the development of vaccines that stimulate the immune system to control infection effectively.